These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32778489)

  • 1. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
    Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
    Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
    Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
    JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial.
    Bertanha M; Camargo PA; Moura R; Yoshida WB; Pimenta RE; Mariúba JV; Alcantara GP; de Paula DR; Sobreira ML
    Medicine (Baltimore); 2016 Sep; 95(39):e4812. PubMed ID: 27684809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
    Nasser MM; Ghoneim BM; Eldaly W; Elmahdy H
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101874. PubMed ID: 38522666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns.
    Fonseca MM; Mocelin FJ; Grill MH; Gianesini S; Miyake K; Argenta R; Pereira AH
    Phlebology; 2023 Apr; 38(3):165-171. PubMed ID: 36657386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial.
    Bertanha M; Sobreira ML; Pinheiro Lúcio Filho CE; de Oliveira Mariúba JV; Farres Pimenta RE; Jaldin RG; Moroz A; Moura R; Rollo HA; Yoshida WB
    Trials; 2014 Dec; 15():497. PubMed ID: 25527165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low concentration of sodium tetradecyl sulfate and hypertonic glucose solution for the treatment of telangiectasia: A prospective randomized clinical trial.
    Bukina OV; Sinitsyn AA; Efremova OI; Pelevin AV
    Phlebology; 2023 Oct; 38(9):622-627. PubMed ID: 37519033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy for lower limb telangiectasias.
    Schwartz L; Maxwell H
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008826. PubMed ID: 22161437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerotherapy of telangiectasias: A prospective, randomized, comparative clinical trial of hypertonic glucose versus sodium tetradecyl sulfate.
    Bukina OV; Sinitsyn AA; Pelevin AV
    Vasc Med; 2021 Jun; 26(3):297-301. PubMed ID: 33733965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.
    Kern P; Ramelet AA; Wutschert R; Bounameaux H; Hayoz D
    Dermatol Surg; 2004 Mar; 30(3):367-72; discussion 372. PubMed ID: 15008862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
    Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
    Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Safety and Efficacy of Foam Sclerotherapy With 1: 2 Polidocanol to Air Ratio Versus 1: 4 Ratio for the Treatment of Reticular Veins of the Lower Extremities.
    Hoss E; Kollipara R; Boen M; Alhaddad M; Goldman MP
    Dermatol Surg; 2020 Dec; 46(12):1715-1720. PubMed ID: 32947299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of essential telangiectasia: effects of increasing concentrations of polidocanol.
    Norris MJ; Carlin MC; Ratz JL
    J Am Acad Dermatol; 1989 Apr; 20(4):643-9. PubMed ID: 2654207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
    Weiss RA; Weiss MA
    J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
    Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study.
    Kern P; Ramelet AA; Wütschert R; Hayoz D
    J Vasc Surg; 2007 Jun; 45(6):1212-6. PubMed ID: 17467226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
    McCoy S; Evans A; Spurrier N
    Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
    Conrad P; Malouf GM; Stacey MC
    Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.